BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 8.06 billion Japanese Yen [US$80.24 million]
of which 99%
was Reagent business),
Falco Holdings Co Ltd
(48.73 billion Japanese Yen [US$485.32 million]
of which 59%
was Medical Test), and
Dr. Lal PathLabs Ltd
based in India
(7.91 billion Indian Rupees [US$117.83 million]
BML Inc reported sales of ¥109.02 billion (US$1.09 billion)
March of 2016.
increase of 4.4%
versus 2015, when the company's sales were ¥104.40 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 35%).
Sales of Medical Information Systems Business saw an increase
that was more than double the company's growth rate: sales were up
9.5% in 2016, from
¥3.61 billion to ¥3.95 billion.
BML Inc also saw significant increases in sales in
Other (up 6.4% to ¥1.50 billion)